Press Release

Sep- 2026 -

4 September

Business Wire

UNCY CLASS ACTION NOTICE: Glancy Prongay Wolke & Rotter LLP Files Securities Fraud Lawsuit On Behalf Of Unicycive Therapeutics, Inc. Investors
Read More »
3 September

Business Wire

ZANVASTRO™ (zilganersen) approved by the FDA as the first and only disease modifying treatment for Alexander disease (AxD) in pediatric and adult patients
Read More »
3 September

MarketersMEDIA Newswire

ResortCleaning Reveals How Room Readiness Delays Impact Revenue
Read More »
3 September

Business Wire

KBRA Assigns AAA Rating to State of Wisconsin General Obligation Bonds of 2026, Series B
Read More »
3 September

Cision PR Newswire
0

EPC Power Announces Sale to Flex for $4.4 Billion
Read More »
3 September

Business Wire

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)
Read More »
3 September

Business Wire

KBRA Assigns A- with Stable Outlook to Monterey Peninsula Airport District Airport Revenue Bonds and TIFIA Loan
Read More »
3 September

Business Wire

PNR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Pentair plc and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit – October 2, 2026 Deadline
Read More »
3 September

Cision PR Newswire
0

KANEKA UBIQUINOL™ WINS NUTRAINGREDIENTS ASIA INGREDIENT OF THE YEAR: HEALTHSPAN AWARD 2026
Read More »
3 September

Business Wire

IPA Capital Markets Arranges $40.3 Million Financing for 312-Unit Birwood Heights in San Antonio
Read More »

Previous page Next page